Feed 7741.T
77

HOYA Corporation 7741.T JPX · Healthcare · Japan

¥23,095.00 -2.02% -¥475.00

Summary

81 / 100 · Bulios Score

What speaks for it

  • Out of every 100 JPY of revenue, 28 JPY is left as net profit.
  • It earns 22 JPY a year on every 100 JPY of invested capital.
  • Earnings per share grew by 17% a year over the last 3 years.
  • It holds more cash than debt: ¥561.9B against ¥42.2B.

What to watch

  • It missed profit estimates 4 times in the last 8 quarters.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Fairly priced
Bulios Fair Price
Fair Value Price today ¥23,095

By our assumptions the price matches the value of the business: the two differ by less than 10 %.

P/E today 27.9 15% lower
5-year average P/E 32.7
P/E today 27.9
Medical - Instruments & Supplies industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 27.9 JPY for 1 JPY of yearly profit. Over the last five years it was 32.7 JPY on average.

Valuation in detail

Is it growing?

Yes, fast

Revenue (JPY)

Diluted EPS (JPY)

  • Analyst estimate

Revenue grew by 12% a year over 5 years. Over the last 3 years it grew by 9.4% a year. For the next fiscal year analysts expect revenue to grow by 11%. Earnings per share grew by 17% a year over the last 3 years.

Growth in detail

Does it make money?

Very well

Where 100 JPY of revenue goes

Net profit, industry median (Medical - Instruments & Supplies) 8.5 JPY

Out of every 100 JPY of revenue, 28 JPY is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

It could repay all its debt from a single year of free cash flow. It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

Small, safe
Yield
0.55%
Paid out of profit
15%

You receive ¥130.00 per share a year. The company covers the payout with ease.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy